JD Health International Inc. (6618.HK)
HKD 28.3
(-1.57%)
HKD 28.3
(-1.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 53.52 Billion | 46.73 Billion | 30.68 Billion | 19.38 Billion | 10.84 Billion | 8.16 Billion |
| Cost of Revenue | 41.66 Billion | 36.84 Billion | 23.48 Billion | 14.46 Billion | 8.02 Billion | 6.19 Billion |
| Gross Profit | 11.86 Billion | 9.89 Billion | 7.19 Billion | 4.91 Billion | 2.81 Billion | 1.97 Billion |
| Operating Expenses | 11.16 Billion | 10.05 Billion | 8.55 Billion | 22.13 Billion | 3.64 Billion | 1.67 Billion |
| Selling, General and Administrative Expenses | 4.65 Billion | 8.96 Billion | 7.7 Billion | 3.95 Billion | 2.04 Billion | 1.42 Billion |
| Research and Development Expenses | 1.22 Billion | 1.06 Billion | 892.91 Million | 609.06 Million | 338.23 Million | 218.28 Million |
| Other Expenses | 5.28 Billion | 82.52 Million | 145.14 Million | -17.49 Billion | -1.26 Billion | 3.56 Million |
| Cost and Expenses | 52.82 Billion | 46.89 Billion | 32.03 Billion | 36.6 Billion | 11.67 Billion | 7.86 Billion |
| Operating Income | 700.7 Million | -145.12 Million | -1.4 Billion | 351.59 Million | 431.58 Million | 307.12 Million |
| Interest Expense | 9.48 Million | 9.09 Million | 5.99 Million | 3.41 Million | 35.5 Million | 150 Thousand |
| Income Tax Expense | 550.46 Million | 312.58 Million | 171.32 Million | 162.75 Million | 137.1 Million | 91.3 Million |
| Earnings before Tax | 2.69 Billion | 695.8 Million | -901.49 Million | -17.07 Billion | -834.7 Million | 306.23 Million |
| Net Income | 2.14 Billion | 380.1 Million | -1.07 Billion | -17.23 Billion | -971.8 Million | 214.92 Million |
| Earnings Per Share Basic | 0.68 | 0.12 | -0.35 | -7.80 | -0.45 | 0.07 |
| Earnings Per Share Diluted | 0.68 | 0.12 | -0.35 | -7.80 | -0.45 | 0.07 |
| Weighted Average Shares Outstanding | 3.14 Billion | 3.1 Billion | 3.09 Billion | 2.2 Billion | 2.14 Billion | 3.12 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.16 Billion | 3.14 Billion | 3.09 Billion | 2.2 Billion | 2.14 Billion | 3.12 Billion |
| Gross Margin | 0.22 | 0.21 | 0.23 | 0.25 | 0.26 | 0.24 |
| EBIT Margin | 0.05 | -0.00 | -0.04 | 0.02 | 0.04 | 0.04 |
| Profit Margin | 0.04 | 0.01 | -0.03 | -0.89 | -0.09 | 0.03 |
| EBITDA | 2.93 Billion | -60.93 Million | -1.37 Billion | 364.5 Million | 436.88 Million | 312.64 Million |
| Earnings Before Tax Margin | 0.01 | -0.00 | -0.05 | 0.02 | 0.04 | 0.04 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 26.41 Billion | 53.52 Billion | 27.11 Billion | 46.73 Billion | 26.51 Billion | 20.22 Billion |
| Cost of Revenue | 20.75 Billion | 41.66 Billion | 20.9 Billion | 36.84 Billion | 21.03 Billion | 15.81 Billion |
| Gross Profit | 5.66 Billion | 11.86 Billion | 6.2 Billion | 9.89 Billion | 5.47 Billion | 4.41 Billion |
| Operating Expenses | 5.8 Billion | 11.16 Billion | 5.3 Billion | 10.05 Billion | 5.79 Billion | 4.25 Billion |
| Selling, General and Administrative Expenses | 5.3 Billion | - | 4.7 Billion | - | 5.09 Billion | 3.87 Billion |
| Research and Development Expenses | 609.63 Million | - | 616.86 Million | - | 580.37 Million | 486.79 Million |
| Other Expenses | - | 193.71 Million | - | 82.52 Million | - | - |
| Cost and Expenses | 26.56 Billion | 52.82 Billion | 26.21 Billion | 46.89 Billion | 26.83 Billion | 20.06 Billion |
| Operating Income | -248.39 Million | 630.84 Million | 879.24 Million | -145.12 Million | -194.18 Million | 49.06 Million |
| Interest Expense | - | 9.48 Million | - | 9.09 Million | - | - |
| Income Tax Expense | 281.23 Million | 550.46 Million | 269.23 Million | 312.58 Million | 158.19 Million | 154.38 Million |
| Earnings before Tax | 862.12 Million | 2.69 Billion | 1.83 Billion | 695.8 Million | 318.46 Million | 377.34 Million |
| Net Income | 580.48 Million | 2.14 Billion | 1.56 Billion | 380.1 Million | 156.55 Million | 223.55 Million |
| Earnings Per Share Basic | 0.19 | - | 0.49 | - | 0.05 | 0.07 |
| Earnings Per Share Diluted | 0.18 | - | 0.49 | - | 0.05 | 0.07 |
| Weighted Average Shares Outstanding | 3.12 Billion | 3.14 Billion | 3.18 Billion | 3.1 Billion | 3.12 Billion | 3.19 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.16 Billion | 3.16 Billion | 3.16 Billion | 3.14 Billion | 3.14 Billion | 3.13 Billion |
| Gross Margin | 0.21 | 0.22 | 0.23 | 0.21 | 0.21 | 0.22 |
| EBIT Margin | -0.01 | - | 0.04 | - | -0.01 | 0.00 |
| Profit Margin | 0.02 | 0.04 | 0.06 | 0.01 | 0.01 | 0.01 |
| EBITDA | -192.25 Million | - | 987.17 Million | - | -160.97 Million | 100.04 Million |
| Earnings Before Tax Margin | -0.01 | 0.01 | 0.03 | -0.00 | -0.01 | 0.00 |
PTIZF
CAOVY
0RP8
IVBXF
ZEO
DMAS